- Home
- FGF vs IRIX Comparison
FGF vs IRIX Comparison
Compare FGF & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGF
- IRIX
- Stock Information
- Founded
- FGF 2012
- IRIX 1989
- Country
- FGF United States
- IRIX United States
- Employees
- FGF N/A
- IRIX N/A
- Industry
- FGF Property-Casualty Insurers
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FGF Finance
- IRIX Health Care
- Exchange
- FGF Nasdaq
- IRIX Nasdaq
- Market Cap
- FGF 20.2M
- IRIX 16.5M
- IPO Year
- FGF N/A
- IRIX 1996
- Fundamental
- Price
- FGF $17.20
- IRIX $1.15
- Analyst Decision
- FGF
- IRIX Hold
- Analyst Count
- FGF 0
- IRIX 1
- Target Price
- FGF N/A
- IRIX $2.00
- AVG Volume (30 Days)
- FGF 1.2K
- IRIX 68.5K
- Earning Date
- FGF 05-19-2025
- IRIX 05-13-2025
- Dividend Yield
- FGF N/A
- IRIX N/A
- EPS Growth
- FGF N/A
- IRIX N/A
- EPS
- FGF N/A
- IRIX N/A
- Revenue
- FGF $17,348,000.00
- IRIX $48,669,000.00
- Revenue This Year
- FGF N/A
- IRIX $9.61
- Revenue Next Year
- FGF N/A
- IRIX N/A
- P/E Ratio
- FGF N/A
- IRIX N/A
- Revenue Growth
- FGF 1.49
- IRIX N/A
- 52 Week Low
- FGF $14.21
- IRIX $0.78
- 52 Week High
- FGF $38.40
- IRIX $3.25
- Technical
- Relative Strength Index (RSI)
- FGF 53.40
- IRIX 53.25
- Support Level
- FGF $16.27
- IRIX $1.14
- Resistance Level
- FGF $17.27
- IRIX $1.33
- Average True Range (ATR)
- FGF 0.30
- IRIX 0.08
- MACD
- FGF 0.20
- IRIX 0.00
- Stochastic Oscillator
- FGF 96.05
- IRIX 41.94
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segments includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.